
Gut microbiota signatures can serve as noninvasive biomarkers to identify KRAS mutation status in colorectal cancer patients and guide personalized treatment.


coremsg

Researchers analyzed gut microbiota from KRAS-mutated and KRAS wild-type colorectal cancer to assess the link between disruptions in the gut microbiome and KRAS mutations in the disease.

Microbial Signature of KRAS-Mutated CRC Identified

gut-microbiome-signatures-linked-to-kras-mutations-in-colorectal-cancer-patients


Gut Microbiome Signatures Linked to KRAS Mutations in Colorectal Cancer Patients
